“…While COVID‐19 has variously dominated hospital functionalities worldwide in the first half of 2020, the passing of this global pandemic will likely see a rapid return to the proliferation of patient‐specific, complex, open‐cellular biomedical implant device development, clinical trials and the establishment of bone‐related surgical service centres producing a wide range of custom bone replacement devices; based in part on contemporary applications and market analyses (Ahangar et al, 2019; Dall’Ava L et al, 2019; Gadia et al, 2018; Huang et al, 2019; Kalaskun, 2017; Lee et al, 2020; Murr, 2019, 2020; Tofail et al, 2018; Wohlers Report, 2019, 2019; Woo et al, 2020; Zhang & Chen, 2019). This trend in global customizing of biomedical devices might be popularly referred to as mass‐personalization which is made possible by 3D printing in point‐of‐care surgical service centres, along with other emerging technologies (Marr, 2020).…”